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Several lines of evidence establish that the crystallizable aspartyl-tRNA synthetase from Baker’s yeast 
contains some covalently bound glucose: (i) a positive staining of the enzyme was obtained after 
polyacrylamide gel electrophoresis followed by the concanavalin A-peroxidase test which is specific for 
glucose and mannose containing proteins; (ii) thin-layer chromatography and gas-liquid chromatography 
revealed the presence of glucose in enzyme hydrolysates; (iii) immunoaffinoelectrophoresis n agarose gels 
containing concanavalin A and antibodies raised against aspartyl-tRNA synthetase showed that the 
enzyme was able to precipitate entirely in the lectin. Finally incubation of the enzyme with [14C]glucose 
or [14C]glucose 6-phosphate led to the incorporation of radioactivity into trichloroacetic acid-precipitable 
protein. Indeed immunoprecipitation of [14C]glucose-labelled aspartyl-tRNA synthetase with specific 
antibodies using the rocket method followed by autoradiography gave a radioactive peak. This last result 
also demonstrates the possibility of in vitro glycosylation of yeast aspartyl-tRNA synthetase. 
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1. INTRODUCTION 
Aminoacyl-tRNA synthetases have been exten- 
sively studied over the last 20 years from many 
viewpoints (review [ 11). Structural studies have 
been carried out on many enzymes from various 
sources and several complete amino acid sequences 
have been established either from the protein itself 
[2] or through DNA cloning and sequencing [3-91. 
Only a few cases of post-translational modifica- 
tions of aminoacyl-tRNA synthetases have been 
reported. They concern essentially the 
phosphorylation of serine residues [lo]. It has been 
shown in our laboratory [l l] that aspartic acid 
could be covalently linked to yeast aspartyl-tRNA 
synthetase and that this attachment was induced by 
the enzyme in the absence of the cognate tRNA 
under conditions where the synthetase activates the 
amino acid into aspartyl-adenylate; i.e., in the 
presence of ATP and MgClz. Glycosylation of 
some aminoacyl-tRNA synthetases has also been 
suggested but only preliminary studies have been 
carried out so far in the cases of rat liver 
threonyl-tRNA synthetase [12] and chloroplast 
leucyl-tRNA synthetase from Euglena gracilis 
[13]. It has been reported [ 14,151 that the lysyl- 
and arginyl-tRNA synthetase complex isolated 
from rat liver contains carbohydrates but the 
chemical nature and amount of carbohydrates 
found raise some questions as to whether these en- 
zymes can be considered genuine glycoproteins. 
Furthermore, the presence of a carbohydrate moie- 
ty in all mammalian aminoacyl-tRNA synthetases 
remains an open question and it is by no means 
established that such a feature represents a major 
difference between eukaryotic and prokaryotic en- 
zymes. To answer these questions a systematic 
analysis of all available synthetases is obviously 
necessary. We have undertaken a study on several 
aminoacyl-tRNA synthetases purified from 
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baker’s yeast. We here report the results obtained 
with the crystallizable aspartyl-tRNA synthetase 
well characterized in our laboratory [16]. 
2. MATERIALS AND METHODS 
2.1. Enzyme 
Aspartyl-tRNA synthetase was purified from 
commercial baker’s yeast (FALA, Strasbourg) 
harvested in the exponential growth phase as in 
[ 171 and adapted in [ 181 for large-scale prepara- 
tions. The pure enzyme crystallizes [la] and ex- 
hibits a specific activity of 600-800 units/mg. One 
unit is that amount of enzyme which catalyzes the 
incorporation of 1 nmol aspartic acid into 
tRNAASP/min under the standard conditions at 
37°C [18]. 
2.2. Chemicals 
Ion-exchange resin AG 501-X8 (D) and agarose 
(standard low-M,) were purchased from Bio-Rad 
Laboratories (Richmond CA). Thin-layer cellulose 
plates were from Macherel-Nagel (Polygram ccl 
400, 20 x 20 cm, Duren). Aniline phthalate spray 
reagent and precoated silica gel plates (HPTLC 
plates, fur nano-DC, 10 x 10 cm) were obtained 
from Merck (Darmstadt). Concanavalin A and 
naphthoresorcinol were from Sigma (St Louis 
MO). Emulfogen BC 720 was from GAF (Paris). 
14C-Labelled D-glucose (300 mCi - mmol-‘) and D- 
glucose 6-phosphate (288 mCi - mmol-‘) were from 
the Commissariat a I’Energie Atomique, and Om- 
nifluor was from New England Nuclear. All other 
chemicals were of analytical grade from Merck. 
2.3. Polyacryiamide gel electrophoresis 
Sodium dodecylsulphate-polyacrylamide gel 
electrophoresis (SDS-PAGE) was carried out as in 
[19] in 11% acrylamide gel slabs of 1 mm thick. 
Protein samples were treated prior to elec- 
trophoresis for 3 min at 100°C in 50 mM Tris buf- 
fer, pH 6.8, containing 2% SDS, 2% fi- 
mercaptoethanol, 15% glycerol and 0.001% 
Bromophenol blue. Glycoproteins were stained by 
the concanavalin A-peroxidase method as in [20]. 
2.4. Thin-layer chromatography 
Protein samples were hydrolyzed with either 1 N 
HCl for 2 h or 2 N HCI for 4 h, at 100°C. 
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Hydrolysates were deionised by passage through a 
column (1.6 x 9 cm) filled with a mixed-bed ion- 
exchange resin AG 501-X8(D). The column was 
eluted with bidistilled water and the eluates were 
evaporated to dryness. The resulting material was 
subjected to ascending thin-layer chromatography 
either on pre-coated silica gel plates with the sol- 
vent system ethyl acetate : propanol-1 :propanol- 
2: water (8 : 5 : 1: 1, by vol.) or on cellulose plates 
with the solvent system ethyl acetate : pyridine : 
water (2: 1: 2, by vol.). Sugars were visualised by 
spraying the dried plates with aniline phthalate or 
naphthoresorcinol [21] followed by heating at 
110°C for 5-20 min depending on the reagent. 
2.5. Gas-liquid chromatography 
The sugar content was estimated by gas-liquid 
chromatography of the trifluoroacetate derivatives 
obtained after methanolysis of the protein [22]. 
2.6. Immunoelectrophoresis and affinoelectro- 
phoresis 
Rocket immunoelectrophoresis was performed 
as in [23]. Immuno-affinoelectrophoresis was car- 
ried out in gels containing specific antibodies (im- 
munoelectrophoresis) and concanavalin A (af- 
finoelectrophoresis) [24] which is a lectin specific 
for cu-D-mannosyl, a-D-glucosyl and sterically 
similar residues. Ten ml of 1% agarose gel (w/v) in 
a 37.5 mM Tris/lOO mM glycine buffer (pH 8.7) 
containing 0.8% Emulfogen were layered onto 
glass plates (10 x 10 cm). The same buffer without 
Emulfogen was put in the electrode compartments. 
Two agarose strips at right angles to the direction 
of migration were cut off the plate and were 
replaced by an agarose strip (2 x 3 cm) containing 
a specific antiserum and an agarose strip (2 x 
3 cm) containing concanavalin A at a concentra- 
tion of 1 mg/ml of agarose solution. Elec- 
trophoresis was carried out at 1.5 V/cm for 18 h. 
After electrophoresis the excess of im- 
munoglobulins and concanavalin A was removed 
by pressing and washing the gel in a 50 mM 
phosphate buffer (pH 7.4) containing 150 mM 
NaCl and in distilled water (2 x 24 h). For protein 
staining, the gel was dried in a stream of warm air 
and immersed for 5 min into a 0.25070 (w/v) 
Coomassie brilliant blue solution. Finally the plate 
was destained in methanol :acetic acid : water 
(4: 1: 5, by vol.). 
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2.7. Incorporation of [14Cjglucose and 
[14C]glucose &phosphate 
Unless otherwise mentioned, the [14C]glucose or 
[i4C]glucose 6-phosphate incorporation into 
aspartyl-tRNA synthetase was followed in 0.2 ml 
reaction mixtures containing 20 mM phosphate 
buffer, pH 7.4, 150 mM NaCl, 50,ug purified en- 
zyme and 4.5 PCi of radioactively-labelled sugar. 
After various incubation times at 4”C, to avoid en- 
zyme denaturation, aliquots (10 ~1) were transfer- 
red onto discs of Whatman 3MM filter paper, 
washed 3-times in 5% trichloroacetic acid at O”C, 
twice in 95% ethanol solutions and finally in 
diethyl ether. The dried filters were placed in a 
solution of 4 g Omnifluor/l of toluene and 
counted for 14C in an Intertechnique liquid scin- 
tillation counter. 
As a control, identical experiments were carried 
out with aspartyl-tRNA synthetase alone or sugar- 
free reaction mixtures. 
3. RESULTS 
3.1. Evidence for the presence of covalently 
bound sugars 
Yeast aspartyl-tRNA synthetase could be stain- 
ed after polyacrylamide gel electrophoresis in the 
presence or absence of SDS either with Coomassie 
brilliant blue (protein staining) or with con- 
canavalin A-peroxidase complex (detected by the 
chromogenic peroxidase substrate, diaminoben- 
zidine) specific for glycoprotein containing man- 
nose and glucose. This preliminary result suggested 
the presence of sugars in the enzyme but the co- 
migration of a contaminating glycoprotein at a 
very low level could not be entirely ruled out by 
such experiments. 
To further establish the presence of covalently 
bound sugars in aspartyl-tRNA synthetase, im- 
munoaffinoelectrophoresis of the enzyme was per- 
formed onto agarose plates containing two strips, 
the lower one with concanavalin A and the upper 
one with specific antibodies raised against yeast 
aspartyl-tRNA synthetase. Under the conditions 
described in section 2, no precipitation occurred in 
the upper strip containing the antibodies indicating 
that aspartyl-tRNA synthetase precipitated entire- 
ly in the lower strip as shown in fig.lA and that 
sugars were covalently linked to enzyme. A control 
experiment was carried out to verify that the en- 
Fig. 1. Immuno-affinoelectrophoresis of aspartyl-tRNA 
synthetase. (A) Well 1: the enzyme was electrophoresed 
in 1% agarose gels (w/v) containing two strips: the lower 
one with concanavalin A (1 mg/ml), the upper one with 
specific antibodies raised against yeast aspartyl-tRNA 
synthetase. No precipitation was observed in the upper 
strip containing the antibodies indicating that 
aspartyl-tRNA synthetase precipitated entirely in the 
lower strip. Well 2: precipitation occurred below the 
upper strip when the lower one was absent. (B) Well 1: 
control experiments showing the precipitation of 
aspartyl-tRNA synthetase below the strip containing its 
specific antibodies due to their electroendosmotic 
migration towards the cathode. Well 2: there is no 
precipitate at all when these antibodies are omitted. + 
and - refer to anode and cathode, respectively. 
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zyme precipitated in the presence of the specific 
antibodies when the strip containing concanavalin 
A was absent (fig.lA). In this case the precipitate 
was just below the upper strip due to the migration 
of the antibodies towards the cathode. This migra- 
tion was caused by electroendosmosis. There was 
no precipitation at all when antibodies were absent 
(fig. 1B). 
The nature of sugars was determined by high 
performance thin layer chromatography 
(HPTLC). After exhaustive dialysis followed by 
hydrolysis with HCl, aspartyl-tRNA synthetase 
yielded free glucose mainly, if not exclusively, in- 
deed no other neutral sugar could be visualised on 
the plates (fig.2). Glucose could be differentiated 
from galactose due to their different staining with 
the naphthoresorcinol reagent; indeed it yields a 
purple colour in contrast to the blue one given by 
Fig.2. Chromatogram of sugars of the carbohydrate 
moiety of aspartyl-tRNA synthetase. Ascending thin- 
layer chromatography was carried out on a pre-coated 
silica gel plate using the solvent system ethyl 
acetate : propanol-1 : propanol-2 : water (8 : 5 : 1: 1, by 
vol.). Numbers correspond to following spots: 1, 
mannose; 2, galactose; 3, glucose; 4, fucose; 5,6, 
aliquots of aspartyl-tRNA synthetase after exhaustive 
dialysis and hydrolysis at 100°C by 1 N HCl for 2 h and 
2 N HCl for 4 h, respectively; 7, aliquot of the solution 
outside the dialysis bag containing the enzyme and 
treated by 2 N HCl for 4 h at 100°C. 
Table 1 
Carbohydrate analysis of aspartyl-tRNA synthetase as 
determined by gas-liquid chromatography 
Carbohydrate mol/mol enzyme 
Ribose 0.03 
Fucose not detected 
Galactose 0.05 
Mannose 0.09 
Glucose 1.97 
N-Acetyl glucosamine 0.09 
N-Acetyl galactosamine 0.04 
Neuraminic acid not detected 
galactose or mannose. In all cases, blank ex- 
periments were carried out on aliquots of the solu- 
tion outside the dialysis bag containing the enzyme 
to check for the absence of any glycopeptide or 
non-covalently bound sugar. 
The results obtained by gas-liquid 
chromatography also show that significant 
amounts of glucose were present in the sample 
despite the prolonged dialysis performed prior to 
their methanolysis. The other sugars usually found 
in most glycoproteins were only present in trace 
amounts (table 1). 
3.2. In vitro glycosylation of yeast aspartyl-tRNA 
synthetase by labeling the enzyme with 
glucose or glucose 6-phosphate 
Aspartyl-tRNA synthetase was incubated at 
4°C with [14C]glucose or [i4C]glucose B-phosphate 
and a 30-fold molar excess of sugar to determine 
whether the enzyme could be glycosylated in vitro. 
The amount of radioactivity incorporated into an 
acid-precipitable fraction was measured after 15 
days: at this stage up to 20 mol of sugars (glucose 
or glucose 6-phosphate) were incorporated per mol 
enzyme. The covalent attachment of radioactive 
sugar to the aspartyl-tRNA synthetase was check- 
ed by immunoelectrophoresis. The antibodies rais- 
ed against he enzyme display a radioactive peak of 
immunoprecipitation (rocket) with aspartyl-tRNA 
synthetase (fig.3). With both glucose and glucose 
6-phosphate we also observed that this in vitro 
glycosylation could be accelerated by addition of a 
yeast crude extract to the purified enzyme (not 
shown). Nevertheless, the experiments performed 
with purified aspartyl-tRNA synthetase alone sug- 
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Fig.3. Rocket immunoelectrophoresis of aspartyl-tRNA 
synthetase against the corresponding antibodies. The 
enzyme was incubated with [14C]glucose prior to the 
experiment and the radioactive peak of 
immunoprecipitation was detected by autoradiography 
using Fuji X-ray films. 
gest that glycosylation can occur through a non- 
enzymatic mechanism. 
4. DISCUSSION 
Glycosylation of hemoglobins [25-281, albumin 
[29], human low density lipoprotein [30] and lens 
crystallins [3 1,321 have recently been reported. The 
covalent binding between glucose and protein in- 
volves free amino groups of the latter. In the case 
of hemoglobins, glycosylation occurs in vivo or in 
vitro by a condensation between glucose and the 
amino-terminal valine of the P-chains. The 
mechanism proposed in [25,33] is the formation of 
a Schiff base with the amino group of valine and 
an Amadori rearrangement to form an acid-stable 
ketoamine adduct. 
The results obtained here are consistent with the 
presence of glucose covalently linked to yeast 
aspartyl-tRNA synthetase. Glucose is sometimes 
an external contaminant present in the biological 
preparations. This is why special precautions were 
taken such as exhaustive dialysis and blank ex- 
periments on buffers and solutions corresponding 
to the last dialysable fractions. Moreover, unlike 
the other yeast aminoacyl-tRNA synthetases 
tested, namely phenylalnyl-, arginyl-, valyl- and 
leucyl-tRNA synthetases, aspartyl-tRNA syn- 
thetase gave a positive and unambiguous answer as 
to the presence of covalently bound glucose. This 
enzyme is extensively studied in our laboratory and 
the elucidation of its amino acid sequence and 
3-dimensional structure are in progress. The 
crystallisable aspartyl-tRNA synthetase has a 
dimeric structure made up of two identical 
subunits since there is only one amino- and one 
carboxy-terminal sequence (Reinbolt et al., per- 
sonal communication). This is somewhat con- 
tradictory to the microheterogeneity (presence of 
several bands) observed by polyacrylamide gel 
electrophoresis and by isoelectrofocusing (Lorber 
et al., personal communication). When isolated, 
the different bands turned out to have the same 
amino- and carboxy-terminal sequences. This 
micro-heterogeneity could well be due, at least 
partly, to glycosylation of aspartyl-tRNA syn- 
thetase. Moreover, during prolonged dialysis a 
significant amount of enzyme precipitates. The in- 
soluble material contains an amount of glucose 
higher than the soluble one. It may well be that 
glycosylation of aspartyl-tRNA synthetase 
enhances its ability to aggregate possibly through 
disulphide bond formation thus giving rise to high 
M, species. 
At present, the physiological significance of 
such a glycosylation is not clear. However this 
covalent attachment of glucose to aspartyl-tRNA 
synthetase is obviously very different from natural 
glycosylation occurring in glycoproteins. 
ACKNOWLEDGEMENTS 
The authors are indebted to Professor J. Bonnet 
for gifts of antibodies against yeast 
aspartyl-tRNA synthetase and Drs J.P. Zanetta 
and B. Lorber for help at some stages of this study. 
They also wish to thank Professor J.P. Ebel for his 
interest during this work. This study was sup- 
ported by grants from the CNRS and the DClCga- 
tion G&r&ale a la Recherche Scientifique et 
Technique. 
REFERENCES 
[l] Schimmel, P.R. and Soll, D. (1979) Annu. Rev. 
Biochem. 48, 601-648. 
[2] Winter, G.P. and Hartley, B.S. (1977) FEBS Lett. 
80, 340-342. 
[3] Putney, S.D., Royal, N.J., Neuman De Vegvar, 
H., Herlihy, W.C., Biemann, K. and Schimmel, 
P.R. (1981) Science 213, 1497-1501. 
179 
Volume 163, number 2 FEBSLETTERS November 1983 
[4] Hall, C.V., Van Cleemput, M., Muench, K.H. and 
Yanofsky, C. (1982) J. Biol. Chem. 257, 
6132-6136. 
[5] Barker, D.G., Ebel, J.P., Jakes, R. and Bruton, 
C.J. (1982) Eur. J. Biochem. 127, 449-457. 
[6] Walter, P., Gangloff, J., Bonnet, J., Boulanger, 
Y., Ebel, J.P. and Fasiolo, F. (1983) Proc. Natl. 
Acad. Sci. USA 80, 2437-2441. 
[7] Hoben, P., Royal, N., Cheung, A., Yamao, F., 
Biemann, K. and Soll, D. (1982) J. Biol. Chem. 
257, 11644-11650. 
(81 Barker, D.G., Bruton, C.J. and Winter, G. (1982) 
FEBS Lett. 150, 419-423. 
[9] Winter, G., Koch, G.L.E., Hartley, B.S. and 
Barker, D.G. (1983) Eur. J. Biochem. 132, 
383-387. 
[lo] Berg, B.H. (1977) Biochim. Biophys. Acta 479, 
152-171. 
[l I] Lorber, B., Kern, D., GiegC, R. and Ebel, J.P. 
(1982) FEBS Lett. 146, 59-64. 
[12] Dignam, J.D., Rhodes, D.G. and Deutscher, M.P. 
(1980) Biochemistry 19, 4978-4984. 
[ 131 Imbault, P., Colas, B., Sarantoglou, V., 
Boulanger, Y. and Weil, J.H. (1981) Biochemistry 
20, 5855-5859. 
1141 Glinski, R.L., Gainey, P.C., Mawhinney, T.P. and 
Hilderman, R.H. (1979) Biochem. Biophys. Res. 
Commun. 88, 1052-1061. 
[15] Dang, C.V., Mawhinney, T.P. and Hilderman, 
R.H. (1982) Biochemistry 21, 4891-4895. 
[la] Dietrich, A., GiegC, R., Comarmond, M.B., 
Thierry, J.C. and Moras, D. (1980) J. Mol. Biol. 
138, 129-135. 
[17] Gangloff, J. and Dirheimer, G. (1973) Biochim. 
Biophys. Acta 294, 263-272. 
1181 Kern, D., Dietrich, A., Fasiolo, F., Renaud, M., 
Giegb, R. and Ebel, J.P. (1977) Biochimie 59, 
453-462. 
1191 Laemmli, U.K. (1970) Nature 227, 680-685. 
1201 Frantz, T., Wlehneldt, T.V., Neuhoff, V. and 
Wachtler, K. (1981) Brain Res. 226, 245-258. 
1211 Lederer, E. and Lederer, M. (1954) 
Chromatography, pp.162-167, Elsevier ,
Amsterdam. 
[22] Zanetta, J.P., Breckenridge, W.C. and Vincendon, 
G. (1972) J. Chromat. 69, 291-304. 
[23] Axelsen, N.H., Bock, E. and Kroll, L. (1973) in: A 
Manual of Quantitative Immunoelectrophoresis. 
Methods and Applications (Axelson, N.H. et al. 
eds) pp.137-143, Universitetsforlaget, Oslo. 
[24] Bog-Hansen, T.C., Bjerrum, O.J. and Brogren, 
C.H. (1977) Anal. Biochem. 81, 78-87. 
[25] Bunn, H.F., Haney, D.N., Gabbay, K.H. and 
Gallop, P.M. (1975) Biochem. Biophys. Res. Com- 
mun. 67, 103-109. 
[26] Stevens, V.J., Vlassara, H., Abati, A. and Cerami, 
A. (1977) J. Biol. Chem. 252, 2998-3002. 
1271 McDonald, M.J., Shapiro, R., Bleichman, M., 
Solway, J. and Bunn, H.F. (1978) J. Biol. Chem. 
253, 2327-2332. 
[28] Bunn, H.F., Shapiro, R., McManus, M., Garrick, 
L., McDonald, M.J., Gallop, P.M. and Gabbay, 
K.H. (1979) J. Biol. Chem. 254, 3892-3898. 
[29] Day, J.F., Thorpe, S.R. and Baynes, J. W. (1979) 
J. Biol. Chem. 254, 595-597. 
[30] Sasaki, J. and Cottam, G.L. (1982) Biochem. Bio- 
phys. Res. Commun. 104, 977-983. 
[31] Stevens, V. J., Rouzer, C.A., Monnier, V.M. and 
Cerami, A. (1978) Proc. Natl. Acad. Sci. USA 75, 
2918-2922. 
[32] Chiou, S.H., Chylack, L.T., Tung, W.H. and 
Bunn, H.F. (1981) J. Biol. Chem. 256, 5176-5180. 
1331 Bunn, H.F., Gabbay, K.H. and Gallop, P.M. 
(1978) Science 200, 21-27. 
180 
